高级搜索
川芎嗪注射液、硝苯吡啶对食管 癌化疗增效作用的临 床研究[J]. 肿瘤防治研究, 2000, 27(03): 215-215. DOI: 10.3971/j.issn.1000-8578.1680
引用本文: 川芎嗪注射液、硝苯吡啶对食管 癌化疗增效作用的临 床研究[J]. 肿瘤防治研究, 2000, 27(03): 215-215. DOI: 10.3971/j.issn.1000-8578.1680
The Clinical Study of Synergism of Ligustrazin Combin ed Nifedipine On Carcinoma of Esophagus With Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2000, 27(03): 215-215. DOI: 10.3971/j.issn.1000-8578.1680
Citation: The Clinical Study of Synergism of Ligustrazin Combin ed Nifedipine On Carcinoma of Esophagus With Chemotherapy[J]. Cancer Research on Prevention and Treatment, 2000, 27(03): 215-215. DOI: 10.3971/j.issn.1000-8578.1680

川芎嗪注射液、硝苯吡啶对食管 癌化疗增效作用的临 床研究

The Clinical Study of Synergism of Ligustrazin Combin ed Nifedipine On Carcinoma of Esophagus With Chemotherapy

  • 摘要: 目的 观察川芎嗪注射液、硝苯吡啶联合应用对食管癌化疗的增效 作用。方法 川芎嗪注射液、硝苯吡啶联合应用于化疗方案中,在随机条件 下与对照组进行比较。结果 川芎嗪注射液、硝苯吡啶联合应用对 化疗确有增 效作用,治疗组CR+PR40%,对照组CR+PR25%,两组差异有显著性(P<0.05)。结 论 本研究结果提示:川芎嗪注射液、硝苯吡啶对化学治疗食道癌有增效作用。

     

    Abstract: Objective To examine the synergism of Ligustrazin Combine d Nifedipine on carcinoma of esophagus with chemotherapy. Methods Lig ustrazin and Nifedipne combined chemotherapy on carcinoma of esophagus treatment, compared The only chemotherapy group randomly. Results the results s howed that the effective rate (CR+PR) of control group were 40% and 25%respectiv ely. Conclusion The results indicted that Ligustrazin combined Nifedi pine have synergism on chemotherapy of carcinoma of carcinoma of esophagus.

     

/

返回文章
返回